Liu, J., Qu, L., Meng, L., & Shou, C. (2019). Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway. J Exp Clin Cancer Res.
Chicago-tyylinen lähdeviittausLiu, Jiafei, Like Qu, Lin Meng, ja Chengchao Shou. "Topoisomerase Inhibitors Promote Cancer Cell Motility Via ROS-mediated Activation of JAK2-STAT1-CXCL1 Pathway." J Exp Clin Cancer Res 2019.
MLA-viiteLiu, Jiafei, Like Qu, Lin Meng, ja Chengchao Shou. "Topoisomerase Inhibitors Promote Cancer Cell Motility Via ROS-mediated Activation of JAK2-STAT1-CXCL1 Pathway." J Exp Clin Cancer Res 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.